Fundraising Fox
Amgen
NASDAQ: AMGNventure arm · Amgen VenturesThousand Oaks, US · Founded 1980 · Delaware corporation · 6 known investors
Find your way into Amgen
Sign up to see every warm intro you have to Amgen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amgen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.
Founders & leadership
Amgen was founded in 1980 by William K. Bowes and George B. Rathmann.
Investors · 6
How we know: Asset Management Company's portfolio page · Not right? Tell us
How we know: Mayfield Fund's portfolio page · Not right? Tell us
How we know: Ridgeback Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements▶$2.5BofferedJan 2015 · 34 investors · BiotechnologyRule 506(b)
- David PiacquadExecutive Officer
- Francois de CarbonnelDirector
- Brian M. McNameeExecutive Officer
- Tyler JacksDirector
- Ronald D. SugarDirector
- Robert A. BradwayExecutive Officer, Director
- David J. ScottExecutive Officer
- Madhavan BalachandranExecutive Officer
- Stuart A. TrossExecutive Officer
- David W. MelineExecutive Officer
- Sean E. HarperExecutive Officer
- Rebecca M. HendersonDirector
- Judith PelhamDirector
- Vance D. CoffmanDirector
- David BaltimoreDirector
- Cynthia M. PattonExecutive Officer
- Greg C. GarlandDirector
- Frank C. HerringerDirector
- Frank J. Biondi, Jr.Director
- Robert A. EckertDirector
- Anthony C. HooperExecutive Officer
- R. Sanders WilliamsDirector
- Offering amount
- $2.5B
- Minimum investment
- $250K
- Sales commissions
- $750K
- Placement agents
- Deutsche Bank Securities Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Banc of America Securities LLC, Goldman, Sachs & Co., Morgan Stanley & Co. Incorporated
- First sale
- Sep 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Amgen mafia →52 people who came through Amgen went on to found or lead other companies.
Acquisitions · 4
Early investors' stakes continue via these dealsAmgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses. The company operates globally with manufacturing facilities across the United States, Europe, and Asia, serving patients and healthcare providers worldwide.
Five Prime Therapeutics was a clinical-stage biotech in South San Francisco developing protein- and antibody-based immuno-oncology therapies, including the FGFR2b-targeting antibody bemarituzumab for gastric cancer.
Micromet was a biopharmaceutical company based in Rockville, MD and Munich, Germany that developed antibody-based cancer therapies using its proprietary BiTE (Bispecific T-cell Engager) platform, including lead candidate blinatumomab.
Nuevolution was a Copenhagen-based biopharmaceutical company developing small-molecule drugs for oncology and chronic inflammatory diseases using its proprietary DNA-encoded chemical library platform, Chemetics.
Frequently asked questions
- What does Amgen do?
- Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.
- Who founded Amgen?
- Amgen was founded by William K. Bowes, George B. Rathmann in 1980.
- Who are Amgen's investors?
- Amgen's investors include Asset Management Company, BOM, Boulder Ventures, Mayfield Fund, Ridgeback Capital, Sunstone Capital.
- Where is Amgen headquartered?
- Amgen is headquartered in Thousand Oaks, US.